During the past decade, Nemocnica s poliklinikou Trebisov a.s. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nemocnica s poliklinikou Trebisov a.s." are "Diabetic Macular Edema" (2 trials), "Macular Edema" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Nemocnica s poliklinikou Trebisov a.s." in a lesser frequency.

Most popular intervention types in "Nemocnica s poliklinikou Trebisov a.s." are "Drug" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (3 trials), "Aflibercept" (2 trials), "Faricimab" (2 trials) and "KSI-301" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnica s poliklinikou Trebisov a.s." are 3 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnica s poliklinikou Trebisov a.s.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Nemocnica s poliklinikou Trebisov a.s., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnica s poliklinikou Trebisov a.s., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".